On July 17, the FDA approved Vivus’ weight-loss medication Qsymia (formerly called Qnexa), just several weeks after the approval of Arena’s Belviq (see new now next in...
Diabetes & Weight Loss News
37 readers recommended
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
36 readers recommended
Dr. Arya Sharma highlights the most important weight loss tip everyone should know and why weight maintenance is a major achievement.
34 readers recommended
The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...
39 readers recommended
On September 17, Vivus announced that its obesity medication Qsymia (formerly Qnexa) is now available on the US market – this happened at least several weeks earlier...
29 readers recommended
What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity.
33 readers recommended
Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...
22 readers recommended
Kelly on the shocking new data just released on diabetes costs and what we can do about it.
35 readers recommended
During the US Open tennis tournament earlier this month, Larry Soler of the Partnership for a Healthier America (PHA) announced a pair of new initiatives to promote...
30 readers recommended
James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .
36 readers recommended
Retrofit CEO Jeff Hyman explains what makes data-driven weight loss – using Skype sessions and Wifi scales– so different.
37 readers recommended
What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.
42 readers recommended
On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...
33 readers recommended
What can obesity learn from seatbelts, airbags, and tobacco? Our interview with Robert Wood Johnson Foundation’s Dr. Marks.
35 readers recommended
How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research.
38 readers recommended
The provocative documentary Fed Up , which offers an unflinching look at the real causes and challenges of America’s obesity epidemic, is currently playing in select...
38 readers recommended
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
32 readers recommended
Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...
The CDC Releases State-by-State Obesity Data; Six States Show Significant Increases in Obesity Rates
35 readers recommended
Twitter summary: CDC releases state-by-state obesity data, several states see increases in adult obesity rates – childhood obesity rates level off The Center for Disease...
45 readers recommended
Twitter summary: After huge anticipation for this innovative drug combination, Novo Nordisk’s Xultophy received approval in Europe for #T2D, 1 st ever basal insulin/GLP-...